Nielsen, Mathias I. http://orcid.org/0000-0002-6823-5354
de Haan, Noortje
Kightlinger, Weston
Ye, Zilu http://orcid.org/0000-0001-8829-6579
Dabelsteen, Sally
Li, Minyan
Jewett, Michael C. http://orcid.org/0000-0003-2948-6211
Bagdonaite, Ieva http://orcid.org/0000-0002-9383-8448
Vakhrushev, Sergey Y. http://orcid.org/0000-0002-0418-5765
Wandall, Hans H. http://orcid.org/0000-0003-0240-9232
Article History
Received: 4 March 2022
Accepted: 30 September 2022
First Online: 21 October 2022
Competing interests
: The authors declare the following competing financial interests: H.H.W. owns stocks and is a consultant for and co-founder of EbuMab, ApS, Hemab, ApS, and GO- Therapeutics, Inc., all not involved in, or related to, the research performed in this study. All other authors declare no conflicts of interest.